It is common knowledge that insulin therapy is not obligatory for patients with type 2 diabetes, but in these patients it is often necessary in progressive insulinopenia, prolonged duration of diabetes, and very poor glycemic control. This evidence concerns the gene INS and type 2 diabetes mellitus.